Allia Health, a Y Combinator Summer 2026 startup, says it has turned its free behavioral health electronic health records system, which it says more than 8,000 clinicians use, into a national clinical group live across 70 locations. The company's own figures and its investors' posts disagree on how far that group reaches.
A YC post reposted by Allia's LinkedIn page said the group is "live in all 50 states across 70 locations." Pioneer Fund partner James Fong, writing on Sept. 3, 2026, put the footprint at 32 states. Both counts come from the company or its backers, and neither has been independently verified.
What Allia is selling
In the YC directory, Allia calls itself the "first full-stack, AI-native clinical group for mental health." Its stated aim is to bring "independent practices into one national clinical group that can deliver, measure, and improve care at scale."
The group is built on top of Allia's EHR. According to the company's website, the software handles intake, scheduling, eligibility checks, documentation, telehealth, measurement-based care and billing. It also includes an AI scribe that produces structured notes, along with e-prescribing through DrFirst, controlled substances included.
Allia's homepage lists several performance figures, all reported by the company: first-pass claim acceptance of 98 to 98.5 percent, more than 90 percent of claims paid in under 14 days, and 92 percent of notes signed the same day.
How the network works
Allia describes the group as a clinically integrated network, a structure in which separate practices adopt shared standards and infrastructure so they can negotiate with insurers as a single entity. Its network page says membership is by invitation only, and it cites delegated and accelerated credentialing (the process of verifying a clinician so insurers will cover their care) and coordinated referrals.
The YC post said the group serves more than 150,000 patients and holds "signed contracts with some of the largest health insurance companies." Allia has not publicly named a single payer, based on the material reviewed for this article.
Conflicting clinician counts

The headcount is where the sources drift apart. The YC post and Fong's Sept. 3 post both cite 70 locations, but Fong wrote that "over 600 clinicians across 70 locations and in 32 states are already in the group." Allia's For Health Systems page, crawled in October 2026, says "550+ licensed clinicians nation-wide." The gap may simply reflect snapshots taken at different times.
An Orange Collective investor memo dated Sept. 1, 2026 repeats the 600-plus figure. It also cites "$50M+ contracted care capacity (annualized)" and says care begins in September 2026. The memo is an investor's write-up of claims made by the company, not an independent assessment.
Recent product releases

The company has shipped several features in recent months. Founder and CEO Amie Leighton introduced Flows, a no-code automation tool inside the EHR, on LinkedIn between September and October 2026. "It's a step toward an Allia that understands how each practice works and actively supports the operational layer behind care," she wrote.
Allia has also added group therapy workflows and a Partner API. According to the company's LinkedIn post, the API lets outside developers find providers, check availability, book or cancel appointments and generate telehealth links. Leighton separately announced a primary care integration program.
Free for clinicians, with revenue elsewhere
The pitch to clinicians is that the software costs nothing. In a Sept. 30, 2025 founder post, co-founder Saroosh Khan wrote that "Individual providers will never be charged to use Allia." He added: "We are not financed by insurers and have no plans to be."
That post is more than a year old. Draper Associates' portfolio page, crawled in September 2026, describes Allia's revenue as coming through value-based partnerships with networks and insurers. In such arrangements, payers reward providers for outcomes rather than the volume of services. Whether that squares with Khan's earlier statement is unclear; the materials reviewed for this article include no public company statement reconciling the two.
On Sept. 14, 2026, a thread in the r/therapists subreddit asked whether the free EHR was legitimate. Such threads reflect sentiment rather than evidence, and they are noted here only as a sign of clinician curiosity.
Team and backers
YC lists two founders, Leighton as CEO and Khan as CTO, with a team size of three. LinkedIn shows two to 10 employees. Allia's About page adds a third co-founder, Lucas Volini, a licensed marriage and family therapist who serves as chief clinical officer. YC's directory lists the company in San Francisco as of late September 2026.
Dealroom lists a $2 million seed round from June 2025 with Boost VC, Draper Associates, Oxford Seed Fund and Arben Ventures, plus the standard $125,000 from YC. No first-party press release for the round turned up, so the amount remains unconfirmed. Pioneer Fund, Orange Collective, Lobster Capital and All Together Capital also list the company.
Competitors
Allia runs a public transparency dashboard that parses rate files from Aetna, Cigna and UnitedHealthcare. It compares platforms including Alma, Headway, Grow Therapy, LifeStance, SonderMind, Talkiatry and Talkspace, and shows a national median of $138 for CPT 90837 (a standard 60-minute psychotherapy code) across selected payers. The data is public and updated quarterly, but it does not necessarily reflect Allia's own contracts.
The rivals are considerably larger. Headway's CEO wrote on Oct. 1, 2026 that more than 90,000 providers accept insurance through its marketplace. Grow Therapy said in a June 24, 2026 post that it supported more than 12,000 providers. Spring Health's newsroom says Alma has more than 26,000 clinicians.
What to watch

Allia's site says routine intake takes five to seven days and urgent cases are seen in under 48 hours. The company has yet to publish the name of a payer or health system partner. Those names would be the clearest test of the 150,000-patient claim.
